| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/19/2010 | CA2464243C Method and composition for dry eye treatment |
| 01/19/2010 | CA2393466C Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 01/19/2010 | CA2321547C Indole derivatives and medicinal compositions containing the same |
| 01/14/2010 | WO2010006117A2 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005533A2 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 01/14/2010 | WO2010005046A1 Anti-angiogenic agent |
| 01/14/2010 | WO2010004982A1 Ameliorating or therapeutic agent for dyslipidemia |
| 01/14/2010 | WO2010003797A1 Hyaluronic acid for corneal wound healing |
| 01/14/2010 | WO2009140205A3 Therapeutic substituted cyclopentanes |
| 01/14/2010 | WO2009132050A3 Auris formulations for treating otic diseases and conditions |
| 01/14/2010 | WO2009083188A3 Compositions and methods for prophylaxis and treatment of cellular degenerative disorders |
| 01/14/2010 | WO2009083185A3 Compositions and methods for prophylaxis and treatment of cellular degenerative ophthalmic disorders |
| 01/14/2010 | US20100010084 High penetration prodrug compositions of retinoids and retinoid-related compounds |
| 01/14/2010 | US20100010082 Formulations for treating eye disorders |
| 01/14/2010 | US20100010057 Thiazole derivatives as inhibitors of p13 kinase |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009952 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 01/14/2010 | US20100009951 Ciclesonide containing sterile aqueous suspension |
| 01/14/2010 | US20100009006 Tasteless nutritional supplement containing free amino acids |
| 01/14/2010 | US20100008993 Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730120A1 Method of treating blepharitis |
| 01/14/2010 | CA2730108A1 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 01/14/2010 | CA2729834A1 Formulations for treating eye disorders |
| 01/14/2010 | CA2729605A1 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 01/14/2010 | CA2729303A1 Treatment of eye diseases and excessive neovascularization using a combined therapy |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143431A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 01/13/2010 | EP2143427A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/13/2010 | EP2143422A1 Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections |
| 01/13/2010 | EP2142551A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1406910B1 Preparation methods of derivatives of bisphosphonates |
| 01/13/2010 | EP1305322B1 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 01/13/2010 | EP1211242B1 Prostaglandin derivatives |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN100579968C Quinazolinone derivatives and their use as CB agonists |
| 01/13/2010 | CN100579576C Entoptic embedding material for preventing aggravation of nearsightedness |
| 01/13/2010 | CN100579537C Centella soft capsule and its preparing method |
| 01/13/2010 | CN100579530C Stabilized compositions comprising therapeutically active agent, citric acid or conjugated base and chlorine dioxide |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | US7645736 injecting an alpha-v. beta 3 or alpha-v, beta 5 inhibitor into the vitreous body of the eye; angiogenesis inhibition; diabetic retinopathy, macular degeneration, myopia, ocular histoplasmosis; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 01/12/2010 | US7645462 Acupoint patch |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2466338C New uses for anti-malarial therapeutic agents |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/07/2010 | WO2010002563A1 Methods and ophtalmic devices used in the treatment of ocular allergies |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001946A1 Triazole derivative or salt thereof |
| 01/07/2010 | WO2010001933A1 Histone modification inhibitor specific to target gene |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001258A2 Inhibition of tumour growth and metastases |
| 01/07/2010 | WO2010000851A2 Methods for modulating angiogenesis via dystrophin dp71 |
| 01/07/2010 | WO2010000661A1 Compounds useful for the prevention or treatment of accomodative asthenopia |
| 01/07/2010 | WO2010000437A1 Antiallergic marine biopolymers |
| 01/07/2010 | WO2010000374A1 Protein complexes and screening methods |
| 01/07/2010 | WO2010000072A1 Method of treating hearing loss using xiap |
| 01/07/2010 | WO2009140204A3 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 01/07/2010 | WO2009131850A3 Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
| 01/07/2010 | WO2009112691A3 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 01/07/2010 | US20100004342 LFA-1 Inhibitors and Use Thereof |
| 01/07/2010 | US20100004339 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists |
| 01/07/2010 | US20100004327 Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor |
| 01/07/2010 | US20100004323 Promoter construct |
| 01/07/2010 | US20100004305 Naphthylmethylimidizoles as therapeutic agents |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004156 Small Compounds That Correct Protein Misfolding and Uses Thereof |
| 01/07/2010 | US20100003354 Linseed Extract Medicament for Application to the Eye |
| 01/07/2010 | US20100003334 Combination of loteprednol etabonate and tobramycin for topical ophthalmic use |
| 01/07/2010 | US20100003323 Hydrophilic matrix containing poorly water-soluble compound and method for producing the same |
| 01/07/2010 | US20100003264 Reduction of Ophthalmalogic Neovascularization |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | CA2729708A1 Compounds useful for the prevention or treatment of accomodative asthenopia |
| 01/07/2010 | CA2729408A1 Triazole derivative or salt thereof |
| 01/07/2010 | CA2729077A1 Methods and ophthalmic devices used in the treatment of ocular allergies |
| 01/07/2010 | CA2728877A1 Method of treating hearing loss using xiap |
| 01/07/2010 | CA2727646A1 Protein complexes and screening methods |
| 01/07/2010 | CA2726221A1 Antiallergic marine biopolymers |
| 01/06/2010 | EP2140878A1 Vaccine against streptococcus pneumoniae |
| 01/06/2010 | EP2140871A1 Suspension for visualization of transparent tissue in eye |
| 01/06/2010 | EP2140863A1 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of neurological disorders |
| 01/06/2010 | EP2139474A2 Transcription factor modulating compounds and methods of use thereof |
| 01/06/2010 | EP2139471A2 Treatment of age-related macular degeneration using inhibitors of complement factor d |
| 01/06/2010 | EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 01/06/2010 | EP1653974B1 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 01/06/2010 | EP1513831B1 Novel compounds, their use and preparation |
| 01/06/2010 | EP1339414B1 L-histidine in ophthalmic solutions |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577651C Lactam compound and medicinal use thereof |
| 01/06/2010 | CN100577202C Pharmacological vitreous body dissolving operation |
| 01/06/2010 | CN100577187C Chinese medicine preparation for treating eye fatigue and its preparing process |
| 01/06/2010 | CN100577180C Application of gambogicacid in preparing medication for restraining angiogenesis |